Exane Derivatives’s CA, Inc. CA Stock Holding History

Exane Derivatives’s Portfolio CA Stock Details CA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,471	Closed	-$638K	–	770
2018 Q3	$638K	Sell	14,471 -760	-5%	-$32.8K	0.12%	148
2018 Q2	$543K	Sell	15,231 -64,512	-81%	-$2.27M	0.09%	175
2018 Q1	$2.67M	Buy	79,743 +67,194	+535%	+$2.34M	0.53%	40
2017 Q4	$417K	Buy	12,549 +533	+4%	+$17.7K	0.07%	189
2017 Q3	$401K	Buy	12,016 +1,201	+11%	+$39.7K	0.08%	148
2017 Q2	$373K	Buy	10,815 +3,093	+40%	+$100K	0.08%	157
2017 Q1	$245K	Buy	7,722 +4,554	+144%	+$147K	0.06%	182
2016 Q4	$101K	Buy	3,168 +2,992	+1,700%	+$95.5K	0.02%	250
2016 Q3	$5.82K	Sell	176 -371,843	-100%	-$12.5M	﹤0.01%	435
2016 Q2	$12.2M	Buy	+372,019	New	+$11.6M	2.02%	14

Other funds holding CA

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Exane Derivatives's CA Position: Q4 2018 in Review

Exane Derivatives sold out of CA, Inc. (CA) in Q4 2018, closing a stake of 14,471 shares — an estimated $638K sold.

Exane Derivatives first reported a position in CA in Q2 2016 and held it in 10 quarters. The position peaked at $12.2M in Q2 2016. 3 funds tracked by Wall St. Rank hold CA as of Q4 2018.

Exane Derivatives reported no remaining CA, Inc. position as of Q4 2018 after selling out during the quarter.
Exane Derivatives sold 14,471 CA, Inc. shares in Q4 2018, an estimated $638K.
Exane Derivatives first reported a position in CA, Inc. in Q2 2016 and held it in 10 quarters.
Exane Derivatives's CA, Inc. position peaked at $12.2M in Q2 2016.
3 funds tracked by Wall St. Rank held CA, Inc. as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.